Literature DB >> 19559119

In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes.

Leonard Moise1, Julie A McMurry, Soren Buus, Sharon Frey, William D Martin, Anne S De Groot.   

Abstract

Epitopes shared by the vaccinia and variola viruses underlie the protective effect of vaccinia immunization against variola infection. We set out to identify a subset of cross-reactive epitopes using bioinformatics and immunological methods. Putative T-cell epitopes were computationally predicted from highly conserved open reading frames from seven complete vaccinia and variola genomes using EpiMatrix. Over 100 epitopes bearing low human sequence homology were selected and assessed in HLA binding assays and in T-cell antigenicity assays using PBMCs isolated from Dryvax-immunized subjects. This experimental validation of computational predictions illustrates the potential for immunoinformatics methods to identify candidate immunogens for a new, safer smallpox vaccine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559119      PMCID: PMC2838212          DOI: 10.1016/j.vaccine.2009.06.018

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  32 in total

Review 1.  Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism.

Authors:  A Sette; J Sidney
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

2.  Modelling the immunogenicity of therapeutic proteins using T cell epitope mapping.

Authors:  A S De Groot; J Rayner; W Martin
Journal:  Dev Biol (Basel)       Date:  2003

Review 3.  Helping the CD8(+) T-cell response.

Authors:  Michael J Bevan
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

4.  Sequence and transcriptional analysis of the vaccinia virus HindIII I fragment.

Authors:  J F Schmitt; H G Stunnenberg
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

5.  Expected adverse events in a mass smallpox vaccination campaign.

Authors:  Alex R Kemper; Matthew M Davis; Gary L Freed
Journal:  Eff Clin Pract       Date:  2002 Mar-Apr

Review 6.  Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes.

Authors:  Helena Reijonen; William W Kwok
Journal:  Methods       Date:  2003-03       Impact factor: 3.608

Review 7.  Smallpox vaccination: a review, part II. Adverse events.

Authors:  Vincent A Fulginiti; Arthur Papier; J Michael Lane; John M Neff; D A Henderson
Journal:  Clin Infect Dis       Date:  2003-07-10       Impact factor: 9.079

8.  Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction.

Authors:  C Sylvester-Hvid; N Kristensen; T Blicher; H Ferré; S L Lauemøller; X A Wolf; K Lamberth; M H Nissen; L Ø Pedersen; S Buus
Journal:  Tissue Antigens       Date:  2002-04

9.  An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling.

Authors:  Lichen Jing; D Huw Davies; Tiana M Chong; Sookhee Chun; Christopher L McClurkan; Jay Huang; Brian T Story; Douglas M Molina; Siddiqua Hirst; Philip L Felgner; David M Koelle
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

10.  Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

Authors:  Ingo Drexler; Caroline Staib; Wolfgang Kastenmuller; Stefan Stevanović; Burkhard Schmidt; François A Lemonnier; Hans-Georg Rammensee; Dirk H Busch; Helga Bernhard; Volker Erfle; Gerd Sutter
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-23       Impact factor: 11.205

View more
  36 in total

1.  Harnessing the power of genomics and immunoinformatics to produce improved vaccines.

Authors:  Leonard Moise; Leslie Cousens; Joanna Fueyo; Anne S De Groot
Journal:  Expert Opin Drug Discov       Date:  2010-12-01       Impact factor: 6.098

2.  T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.

Authors:  D Huw Davies; Sookhee Chun; Gary Hermanson; Jo Anne Tucker; Aarti Jain; Rie Nakajima; Jozelyn Pablo; Philip L Felgner; Xiaowu Liang
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

3.  A high throughput MHC II binding assay for quantitative analysis of peptide epitopes.

Authors:  Regina Salvat; Leonard Moise; Chris Bailey-Kellogg; Karl E Griswold
Journal:  J Vis Exp       Date:  2014-03-25       Impact factor: 1.355

4.  VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone.

Authors:  Leonard Moise; R Mark Buller; Jill Schriewer; Jinhee Lee; Sharon E Frey; David B Weiner; William Martin; Anne S De Groot
Journal:  Vaccine       Date:  2010-11-04       Impact factor: 3.641

5.  Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus.

Authors:  Brian C Schanen; Anne S De Groot; L Moise; Matt Ardito; Elizabeth McClaine; William Martin; Vaughan Wittman; William L Warren; Donald R Drake
Journal:  Vaccine       Date:  2011-02-22       Impact factor: 3.641

6.  TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates.

Authors:  Sinu Paul; John Sidney; Alessandro Sette; Bjoern Peters
Journal:  Curr Protoc Immunol       Date:  2016-08-01

Review 7.  VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.

Authors:  Pierre Leblanc; Leonard Moise; Cybelle Luza; Kanawat Chantaralawan; Lynchy Lezeau; Jianping Yuan; Mary Field; Daniel Richer; Christine Boyle; William D Martin; Jordan B Fishman; Eric A Berg; David Baker; Brandon Zeigler; Dale E Mais; William Taylor; Russell Coleman; H Shaw Warren; Jeffrey A Gelfand; Anne S De Groot; Timothy Brauns; Mark C Poznansky
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 8.  Smallpox vaccines for biodefense.

Authors:  Richard B Kennedy; Inna Ovsyannikova; Gregory A Poland
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

9.  Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein.

Authors:  Martha Sedegah; Yohan Kim; Bjoern Peters; Shannon McGrath; Harini Ganeshan; Jennylynn Lejano; Esteban Abot; Glenna Banania; Maria Belmonte; Renato Sayo; Fouzia Farooq; Denise L Doolan; David Regis; Cindy Tamminga; Ilin Chuang; Joseph T Bruder; C Richter King; Christian F Ockenhouse; Bart Faber; Edmond Remarque; Michael R Hollingdale; Thomas L Richie; Alessandro Sette
Journal:  Malar J       Date:  2010-08-24       Impact factor: 2.979

10.  HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity.

Authors:  Sinu Paul; Daniela Weiskopf; Michael A Angelo; John Sidney; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2013-11-04       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.